Synergistic anticancer effects of the 9.2.27PE immunotoxin and ABT-737 in melanoma.

In cancer, combinations of drugs targeting different cellular functions is well accepted to improve tumor control. We studied the effects of a Pseudomonas exotoxin A (PE)-based immunotoxin, the 9.2.27PE, and the BH-3 mimetic compound ABT-737 in a panel of melanoma cell lines. The drug combination re...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Karianne Risberg, Øystein Fodstad, Yvonne Andersson
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-01-01
Online Access:	http://europepmc.org/articles/PMC3168478?pdf=render

Similar Items

ABT-737 synergizes with Bortezomib to kill melanoma cells
by: Steven N. Reuland, et al.
Published: (2012-02-01)

Proteasomal degradation of Mcl-1 by maritoclax induces apoptosis and enhances the efficacy of ABT-737 in melanoma cells.
by: Manoj K Pandey, et al.
Published: (2013-01-01)

OBATOCLAX and ABT-737 induce ER stress responses in human melanoma cells that limit induction of apoptosis.
by: David Wroblewski, et al.
Published: (2013-01-01)

Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy.
by: Ryuji Yamaguchi, et al.
Published: (2011-01-01)

Melatonin Can Modulate the Effect of Navitoclax (ABT-737) in HL-60 Cells
by: Alexey Lomovsky, et al.
Published: (2020-11-01)

Evaluating the stability and efficacy of fractal-fractional models in reproductive cancer apoptosis with ABT-737
by: Kottakkaran Sooppy Nisar, et al.
Published: (2025-01-01)

Rational Formulation of targeted ABT-737 nanoparticles by self-assembled polypeptides and designed peptides
by: Polina Aibinder, et al.
Published: (2024-02-01)

The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma
by: Fuchs Jörg, et al.
Published: (2011-08-01)

Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells.
by: Hong Zhu, et al.
Published: (2012-01-01)

The inhibition of Beclin1-dependent autophagy sensitizes PTC cells to ABT737-induced death
by: Ning Hu, et al.
Published: (2024-03-01)

ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
by: S Cristofanon, et al.
Published: (2012-11-01)

ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer
by: Eun Young Kim, et al.
Published: (2017-04-01)

Correction: ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells
by: S. Cristofanon, et al.
Published: (2024-09-01)

Inhibition of the MDM2 E3 Ligase induces apoptosis and autophagy in wild-type and mutant p53 models of multiple myeloma, and acts synergistically with ABT-737.
by: Dongmin Gu, et al.
Published: (2014-01-01)

Comparison of putative BH3 mimetics AT-101, HA14-1, sabutoclax and TW-37 with ABT-737 in platelets
by: Hao Wei, et al.
Published: (2021-01-01)

HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines
by: Haidar Akl, et al.
Published: (2013-04-01)

The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders
by: Aude Robert, et al.
Published: (2020-10-01)

ABT-737 induces Bim expression via JNK signaling pathway and its effect on the radiation sensitivity of HeLa cells.
by: Huan Wang, et al.
Published: (2012-01-01)

Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus
by: Marta Borowiec, et al.
Published: (2016-11-01)

ABT737通过激活JNK/c-Jun通路上调Bim诱导宫颈癌细胞凋亡
Published: (2013-01-01)

Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties
by: Koji Kawakami, et al.
Published: (2006-01-01)

ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells
by: Ricardo Parrondo, et al.
Published: (2013-09-01)

BMX Acts Downstream of PI3K to Promote Colorectal Cancer Cell Survival and Pathway Inhibition Sensitizes to the BH3 Mimetic ABT-737
by: Danielle S. Potter, et al.
Published: (2014-02-01)

BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?
by: Sachiko Kawashima-Goto, et al.
Published: (2015-01-01)

B-cell lymphoma 2 inhibitor ABT-737 induces Beclin1- and reactive oxygen species-dependent autophagy in Adriamycin-resistant human hepatocellular carcinoma cells
by: Xiaoxiao Yao, et al.
Published: (2017-03-01)

ABT737通过延迟宫颈癌细胞放射后DNA损伤修复及诱导凋亡而增敏放疗
Published: (2013-01-01)

Synergistic anticancer effects of ABT-199 and Vorinostat encapsulated in PLGA nanoparticles: Formulation, characterization, and antiproliferative effects against colorectal cancer cells.
by: Dina Raed Abu Alsamen, et al.
Published: (2025-01-01)

In vitro evidence of HER2-selective cytotoxicity by scFv(Herceptin)-PE-STXA immunotoxin in gastric cancer cells
by: Hamid Sedighian, et al.
Published: (2025-09-01)

Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells
by: Hua Zhang, et al.
Published: (2011-07-01)

Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25
by: Yanjie Peng, et al.
Published: (2023-05-01)

Bouganin, an Attractive Weapon for Immunotoxins
by: Massimo Bortolotti, et al.
Published: (2018-08-01)

Production and Verification of Anti-Tumor Activity of Monoclonal Anti-EGFR-Recombinant PE38 Immunotoxin in A431 Tumor Cells
by: Khalil Hajiasgharzadeh, et al.
Published: (2021-07-01)

Immunotoxins: From Design to Clinical Application
by: Robert J. Kreitman, et al.
Published: (2021-11-01)

Toxin and Immunotoxin Based Therapeutic Approaches
by: Massimo Bortolotti, et al.
Published: (2022-01-01)

The Boeing 737 Max Saga: Automating Failure
by: Chris Palmer
Published: (2020-02-01)

BH3 mimetic ABT-263 enhances the anticancer effects of apigenin in tumor cells with activating EGFR mutation
by: Yihong Zhan, et al.
Published: (2019-07-01)

Immunotoxin: A new tool for cancer therapy
by: Hossein Allahyari, et al.
Published: (2017-02-01)

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors
by: Brendan L. Hagerty, et al.
Published: (2020-06-01)

Development of Recombinant Immunotoxins for Hairy Cell Leukemia
by: Robert J. Kreitman, et al.
Published: (2020-08-01)

Antibody-Based Immunotoxins for Colorectal Cancer Therapy
by: Laura Sanz, et al.
Published: (2021-11-01)